The demonstration that the reactivation of the MECP2 gene in a mouse model can rescue large part of the Rett syndrome-like phenotypes has revealed that the disease is reversible, paving the way towards the search for new treatments [58,60]. This evidence concerns the gene MECP2 and atypical Rett syndrome.